Hepatitis B and C

Clin Geriatr Med. 2014 Feb;30(1):149-67. doi: 10.1016/j.cger.2013.10.012.

Abstract

Hepatitis B and hepatitis C are common predisposing factors leading to cirrhosis and liver cancer. Therapies for hepatitis B suppress viral replication and improve morbidity and mortality. Treatment and evaluation of hepatitis B should be similar in all age groups. This article discusses special topics related to hepatitis B and the elderly. Hepatitis C is a treatable disease whose treatment can lead to viral eradication. This article discusses key points regarding hepatitis C diagnosis and treatment in the context of new advances in disease staging and treatment, with special attention on hepatitis C infection in the elderly.

Keywords: Antiviral therapy; Elderly; Hepatitis B; Hepatitis C; Interferon.

Publication types

  • Review

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use*
  • Disease Management
  • Health Transition
  • Hepatitis B* / complications
  • Hepatitis B* / diagnosis
  • Hepatitis B* / epidemiology
  • Hepatitis B* / immunology
  • Hepatitis B* / physiopathology
  • Hepatitis C* / complications
  • Hepatitis C* / diagnosis
  • Hepatitis C* / epidemiology
  • Hepatitis C* / immunology
  • Hepatitis C* / physiopathology
  • Humans
  • Liver Diseases / diagnosis
  • Liver Diseases / etiology
  • Liver Diseases / prevention & control*
  • Mass Screening / methods
  • Mass Screening / organization & administration
  • Monitoring, Immunologic / methods
  • Prevalence
  • Risk Factors
  • Treatment Outcome

Substances

  • Antiviral Agents